Back
Compare AU
Compare RARI vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Industry & Region
Country Exposure
RARI | DRUG | |
|---|---|---|
Australia | 98.76 % | |
New Zealand | 1.24 % | |
United States | 71.71 % | |
Switzerland | 8.14 % | |
Denmark | 6.30 % | |
United Kingdom of Great Britain and Northern Ireland | 5.41 % | |
Japan | 3.72 % | |
France | 2.94 % | |
Germany | 0.47 % | |
Korea | 0.35 % | |
China | 0.35 % | |
Netherlands | 0.33 % | |
Belgium | 0.27 % |
Industry Exposure
Key differences
•
RARI has a lower allocation (10.45 %) in the Health Care sector than DRUG (24.12 %).
•
The most popular industries that RARI is exposed to are Financials (63.37 %), Health Care (10.45 %), and Consumer Discretionary (8.60 %). Comparatively, DRUG is most exposed to Other (75.67 %), Communication Services (33.53 %), and Health Care (24.12 %).
RARI | DRUG | |
|---|---|---|
Financials | 63.37 % | |
Health Care | 10.45 % | 24.12 % |
Consumer Discretionary | 8.60 % | |
Communication Services | 6.37 % | 33.53 % |
Real Estate | 6.26 % | |
Materials | 5.48 % | |
Industrials | 4.94 % | 0.10 % |
Other | 75.67 % | |
Information Technology | 0.21 % | |
Consumer Staples | 0.14 % |